BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9745560)

  • 1. Transplantation of vascularized allogeneic skeletal muscle for scalp reconstruction in renal transplant patient.
    Jones TR; Humphrey PA; Brennan DC
    Transplant Proc; 1998 Sep; 30(6):2746-53. PubMed ID: 9745560
    [No Abstract]   [Full Text] [Related]  

  • 2. Transplantation of vascularized allogeneic skeletal muscle for scalp reconstruction in a renal transplant patient.
    Jones TR; Humphrey PA; Brennan DC
    Transplantation; 1998 Jun; 65(12):1605-10. PubMed ID: 9665077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival of limb allografts after weaning of cyclosporine: possible role of microchimerism.
    Durlik M; Lukomska B; Namysłowski A; Janczewska S; Cybulska E; Olszewski WL
    Transplant Proc; 1997; 29(1-2):1226-7. PubMed ID: 9123285
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerance to vascularized musculoskeletal allografts.
    Mathes DW; Bourget JL; Randolph MA; Solari MG; Wu A; Sachs DH; Lee WP
    Transplant Proc; 2001; 33(1-2):616-7. PubMed ID: 11266984
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of swine model in transplantation of vascularized skeletal tissue allografts.
    Lee WP; Rubin JP; Cober S; Ierino F; Randolph MA; Sachs DH
    Transplant Proc; 1998 Sep; 30(6):2743-5. PubMed ID: 9745559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced severity of acute rejection in hepatitis C virus positive renal allograft recipients: are milder immunosuppressive regimens advisable?
    Pascual J; Crespo M; Mateos ML; Marcén R; Orofino L; Burgos FJ; Liaño F; Ortuño J
    Transplant Proc; 1998 Jun; 30(4):1329-30. PubMed ID: 9636540
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversal of experimental small bowel transplantation rejection with cyclosporine A.
    Liu Q; Yang R; Grosfeld JL; Collins MH; Pescovitz MD
    Transplant Proc; 1996 Oct; 28(5):2508-9. PubMed ID: 8907925
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: implications for clinical composite tissue transplantation.
    Jones NF; Hebebrand D; Buttemeyer R; Zhao M; Benhaim P; Rao U
    Plast Reconstr Surg; 2001 Mar; 107(3):777-84. PubMed ID: 11304605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcine small bowel transplantation with rapamycin-based induction immunosuppression and short-course cyclosporine or FK 506 therapy.
    Cohen DS; Fisher RA; Shapiro JH; Goggins WC; Tawes JW; Mills S; Contos M; Ham JM; Schroeder TJ
    Transplant Proc; 1996 Oct; 28(5):2501-5. PubMed ID: 8907923
    [No Abstract]   [Full Text] [Related]  

  • 10. Rejection pattern of cardiac and skeletal muscle allografts: implications for surveillance of cardiac rejection.
    Benedetti E; Blanchard J; Sekosan M; Raofi V; Dunn T; Lutrin F; Massad M
    Transplant Proc; 1998 Aug; 30(5):1929. PubMed ID: 9723338
    [No Abstract]   [Full Text] [Related]  

  • 11. Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts.
    Murase N; Fujisaki S; Tanabe M; Tsamandas AC; Todo S; Starzl TE; Demetris AJ
    Transplant Proc; 1994 Jun; 26(3):1517-8. PubMed ID: 7518139
    [No Abstract]   [Full Text] [Related]  

  • 12. A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients.
    Goring SM; Levy AR; Ghement I; Kalsekar A; Eyawo O; L'Italien GJ; Kasiske B
    Curr Med Res Opin; 2014 Aug; 30(8):1473-87. PubMed ID: 24628478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
    Zhu L; Ding T; Wang XX; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-Deoxyspergualin in experimental transplant models: a review.
    Kaufman DB
    Transplant Proc; 1996 Apr; 28(2):868-70. PubMed ID: 8623440
    [No Abstract]   [Full Text] [Related]  

  • 15. Intrathymic cell allografts followed through a major graft challenge.
    Buck BE; Carreño MR; Malinin TI
    Transplant Proc; 1997 Jun; 29(4):2080-2. PubMed ID: 9193536
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of heart allograft and kidney xenograft rejection by monoclonal antibody to CD45RB.
    Zhang Z; Zhong R; Jiang J; Wang J; Garcia B; Le Feuvre C; White M; Stiller C; Lazarovits A
    Transplant Proc; 1997; 29(1-2):1253. PubMed ID: 9123294
    [No Abstract]   [Full Text] [Related]  

  • 17. Sirolimus antirejection therapy for renal transplantation with cyclosporine-based immunosuppression: case reports.
    Tsai MK; Hu RH; Lee PH
    Transplant Proc; 2003 Feb; 35(1):219-20. PubMed ID: 12591371
    [No Abstract]   [Full Text] [Related]  

  • 18. Trial of steroid withdrawal in renal transplant recipients with long-term--surviving allograft.
    Mizuno Y; Kikuchi H; Fujimori K; Doi H; Orii T; Ohkohchi N; Satomi S
    Transplant Proc; 2000 Nov; 32(7):1677-8. PubMed ID: 11119888
    [No Abstract]   [Full Text] [Related]  

  • 19. Withdrawal of steroids from a cyclosporine-based regimen: pro.
    Ponticelli C
    Transplant Proc; 1998 Aug; 30(5):1782-4. PubMed ID: 9723281
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term experience with mycofenolate mofetil in the prevention of renal allograft rejection.
    Behrend M; Lueck R; Pichlmayr R
    Transplant Proc; 1997 Nov; 29(7):2927-9. PubMed ID: 9365617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.